178
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists

, , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaoning Wu, Yiwen Shi, Jialing Zhou, Yameng Sun, Hongxin Piao, Wei Jiang, Anlin Ma, Yongpeng Chen, Mingyi Xu, Wen Xie, Jun Cheng, Shibin Xie, Jia Shang, Jilin Cheng, Qing Xie, Huiguo Ding, Xuqing Zhang, Lang Bai, Mingxiang Zhang, Bingqiong Wang, Shuyan Chen, Hong Ma, Xiaojuan Ou, Jidong Jia & Hong You. (2018) Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study. Expert Opinion on Biological Therapy 18:sup1, pages 61-69.
Read now

Articles from other publishers (15)

M.S. Espinar-Buitrago, E. Vazquez-Alejo, E. Magro-Lopez, L. Tarancon-Diez, M. Leal & M.A. Muñoz-Fernandez. (2023) Immune modulation via dendritic cells by the effect of Thymosin-alpha-1 on immune synapse in HCMV infection. International Immunopharmacology 125, pages 111103.
Crossref
M. S. Espinar-Buitrago, L. Tarancon-Diez, E. Vazquez-Alejo, E. Magro-Lopez, M. Genebat, F. Romero-Candau, M. Leal & M. A. Muñoz-Fernandez. (2023) The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2. Immunity & Ageing 20:1.
Crossref
Daniela Ricci, Marilena Paola Etna, Martina Severa, Stefano Fiore, Fabiana Rizzo, Marco Iannetta, Massimo Andreoni, Stefano Balducci, Paola Stefanelli, Anna Teresa Palamara & Eliana Marina Coccia. (2023) Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model. International Immunopharmacology 117, pages 109996.
Crossref
Yiting Wei, Yunpeng Zhang, Pengcheng Li, Chunguang Yan & Lixin Wang. (2023) Thymosin α-1 in cancer therapy: Immunoregulation and potential applications. International Immunopharmacology 117, pages 109744.
Crossref
Fadi Shehadeh, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski & Eleftherios Mylonakis. (2023) A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection. The Journal of Infectious Diseases 227:2, pages 226-235.
Crossref
Jing Peng, Ming Ni, Dunfeng Du, Yanjun Lu, Juan Song, Weiyong Liu, Na Shen, Xiong Wang, Yaowu Zhu, Bruce A. Vallance, Ziyong Sun & Hong Bing Yu. (2021) Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Meiyu Chen, Yu Jiang, Xiaohui Cai, Xuzhang Lu & Hongying Chao. (2021) Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma. International Immunopharmacology 98, pages 107829.
Crossref
Jiao Liu, Yanfei Shen, Zhenliang Wen, Qianghong Xu, Zhixiong Wu, Huibin Feng, Zhongyi Li, Xuan Dong, Sisi Huang, Jun Guo, Lidi Zhang, Yizhu Chen, Wenzhe Li, Wei Zhu, Hangxiang Du, Yongan Liu, Tao Wang, Limin Chen, Jean-Louis Teboul, Djillali Annane & Dechang Chen. (2021) Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study. Frontiers in Immunology 12.
Crossref
Melissa Bersanelli, Diana Giannarelli, Alessandro Leonetti, Sebastiano Buti, Marcello Tiseo, Antonio Nouvenne, Andrea Ticinesi, Tiziana Meschi, Giuseppe Procopio & Riccardo Danielli. (2021) The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients. Future Oncology 17:9, pages 1097-1104.
Crossref
Ming Wu, Jing-jing Ji, Li Zhong, Zi-yun Shao, Qi-feng Xie, Zhe-ying Liu, Cong-lin Wang, Lei Su, Yong-wen Feng, Zhi-feng Liu & Yong-ming Yao. (2020) Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study. International Immunopharmacology 88, pages 106873.
Crossref
Martina Severa, Jing Zhang, Elena Giacomini, Fabiana Rizzo, Marilena Paola Etna, Melania Cruciani, Enrico Garaci, Michael Chopp & Eliana Marina Coccia. (2019) Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application. Multiple Sclerosis and Related Disorders 27, pages 52-60.
Crossref
Yu-Ming Wang, Ke Li, Xiao-Guang Dou, Han Bai, Xi-Ping Zhao, Xiong Ma, Lan-Juan Li, Zhi-Shui Chen & Yuan-Cheng Huang. 2019. Acute Exacerbation of Chronic Hepatitis B. Acute Exacerbation of Chronic Hepatitis B 273 370 .
Roger Davies, Kieran O’Dea & Anthony Gordon. (2018) Immune therapy in sepsis: Are we ready to try again?. Journal of the Intensive Care Society 19:4, pages 326-344.
Crossref
Elena Giacomini, Fabiana Rizzo, Marilena P Etna, Melania Cruciani, Rosella Mechelli, Maria Chiara Buscarinu, Francesca Pica, Cartesio D’Agostini, Marco Salvetti, Eliana M Coccia & Martina Severa. (2017) Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients. Multiple Sclerosis Journal 24:2, pages 127-139.
Crossref
Fang Liu, Hong-Mei Wang, Tiansheng Wang, Ya-Mei Zhang & Xi Zhu. (2016) The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials. BMC Infectious Diseases 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.